BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2319808)

  • 1. Proliferation and differentiation of erythroleukemia cell line (ELM-I-1) in response to erythropoietin and interleukin 3.
    Shiozaki M; Itoh K; Mori KJ
    Leuk Res; 1990; 14(3):287-91. PubMed ID: 2319808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both stroma and stem cell factor maintain long-term growth of ELM erythroleukemia cells, but only stroma prevents erythroid differentiation in response to erythropoietin and interleukin-3.
    O'Prey J; Leslie N; Itoh K; Ostertag W; Bartholomew C; Harrison PR
    Blood; 1998 Mar; 91(5):1548-55. PubMed ID: 9473219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of nuclear proto-oncogene expression by erythropoietin (Epo) in Epo-responsive murine cell lines.
    Tsuda H; Aso N; Sawada T; Hata H; Kawakita M; Mori KJ; Takatsuki K
    Int J Cell Cloning; 1991 Mar; 9(2):123-33. PubMed ID: 2037810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin rapidly reduces phosphorylation of a membrane protein in a murine erythroleukemia cell line.
    Sawada T; Tsuda H; Mori KJ; Kawakita M; Takatsuki K
    Int J Hematol; 1991 Apr; 54(2):109-15. PubMed ID: 1836139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activating mutation in the kit receptor abolishes the stroma requirement for growth of ELM erythroleukemia cells, but does not prevent their differentiation in response to erythropoietin.
    Leslie NR; O'Prey J; Bartholomew C; Harrison PR
    Blood; 1998 Dec; 92(12):4798-807. PubMed ID: 9845547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 (IL-2) induces erythroid differentiation and tyrosine phosphorylation in ELM-I-1 cells transfected with a human IL-2 receptor beta chain cDNA.
    Imada K; Tsudo M; Kodaka T; Itoh K; Arima N; Hattori T; Okuma M; Uchiyama T
    Biochem Biophys Res Commun; 1992 Oct; 188(1):352-7. PubMed ID: 1384486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells.
    Kubota Y; Tanaka T; Yamaoka G; Yamaguchi M; Ohnishi H; Kawanishi K; Takahara J; Irino S
    Leukemia; 1996 Apr; 10(4):720-6. PubMed ID: 8618453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle.
    Carroll M; Zhu Y; D'Andrea AD
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2869-73. PubMed ID: 7708739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
    Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
    Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7.
    Komatsu N; Yamamoto M; Fujita H; Miwa A; Hatake K; Endo T; Okano H; Katsube T; Fukumaki Y; Sassa S
    Blood; 1993 Jul; 82(2):456-64. PubMed ID: 8329702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective block in erythropoietin-induced differentiation of growth factor-independent retrovirally-infected TF-1 cells.
    Percy MJ; Lappin TR; Buckley OM; McMullin MF
    Leuk Res; 1997 Jul; 21(7):657-66. PubMed ID: 9301687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid protein tyrosine phosphorylation selectively induced in murine responsive ELM-I-1 cells by erythropoietin.
    Sawada T; Tsuda H; Kawakita M; Takatsuki K
    Exp Hematol; 1992 Jun; 20(5):629-32. PubMed ID: 1587309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
    EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific binding of erythropoietin to its receptor on responsive mouse erythroleukemia cells.
    Todokoro K; Kanazawa S; Amanuma H; Ikawa Y
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4126-30. PubMed ID: 3035570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-3/erythropoietin fusion proteins: in vitro effects on hematopoietic cells.
    Weich NS; Tullai J; Guido E; McMahon M; Jolliffe LK; Lopez AF; Vadas MA; Lowry PA; Quesenberry PJ; Rosen J
    Exp Hematol; 1993 May; 21(5):647-55. PubMed ID: 8513865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth signal erythropoietin activates the same tyrosine kinases as interleukin 3, but activates only one tyrosine kinase as differentiation signal.
    Kuramochi S; Chiba T; Amanuma H; Tojo A; Todokoro K
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1103-9. PubMed ID: 1722396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1.
    Kitamura T; Tojo A; Kuwaki T; Chiba S; Miyazono K; Urabe A; Takaku F
    Blood; 1989 Feb; 73(2):375-80. PubMed ID: 2537111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin-dependent suppression of the expression of the beta subunits of the interleukin-3 receptor during erythroid differentiation.
    Carta C; Campisi S; Migliaccio G; Migliaccio AR
    Blood Cells Mol Dis; 2000 Oct; 26(5):467-78. PubMed ID: 11112384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
    Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
    Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.